CorMedix CFO Susan Blum’s RSU Buy Signals Strong Insider Confidence
CorMedix CFO Susan Blum’s 72,820‑RSU purchase shows insider confidence—doubling her stake and boosting investor optimism amid strong earnings and market rally.
4 minutes to read
CorMedix Inc
CorMedix Insider Buy Signals Confidence in DefenCath’s Sepsis Therapy
CorMedix insider buy shows confidence amid regulatory scrutiny; DefenCath offers a new sepsis therapy with solid safety data, but investors must watch CMS reimbursement and Phase III results for upside.
4 minutes to read